share_log

Edgewell Personal Care Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Edgewell Personal Care Company Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Edgewell个人护理公司刚刚超出了收益预期:以下是分析师认为接下来会发生的事情
Simply Wall St ·  05/11 21:14

It's been a good week for Edgewell Personal Care Company (NYSE:EPC) shareholders, because the company has just released its latest second-quarter results, and the shares gained 5.7% to US$39.97. The result was positive overall - although revenues of US$599m were in line with what the analysts predicted, Edgewell Personal Care surprised by delivering a statutory profit of US$0.72 per share, modestly greater than expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. With this in mind, we've gathered the latest statutory forecasts to see what the analysts are expecting for next year.

对于Edgewell个人护理公司(纽约证券交易所代码:EPC)的股东来说,这是美好的一周,因为该公司刚刚发布了最新的第二季度业绩,股价上涨了5.7%,至39.97美元。总体业绩是积极的——尽管收入为5.99亿美元,与分析师的预测一致,但Edgewell Personal Care惊讶地实现了每股0.72美元的法定利润,略高于预期。对于投资者来说,盈利是一个重要时刻,因为他们可以追踪公司的业绩,查看分析师对明年的预测,看看对公司的情绪是否发生了变化。考虑到这一点,我们收集了最新的法定预测,以了解分析师对明年的预期。

earnings-and-revenue-growth
NYSE:EPC Earnings and Revenue Growth May 11th 2024
纽约证券交易所:EPC收益和收入增长 2024年5月11日

Following last week's earnings report, Edgewell Personal Care's six analysts are forecasting 2024 revenues to be US$2.29b, approximately in line with the last 12 months. Statutory per-share earnings are expected to be US$2.51, roughly flat on the last 12 months. In the lead-up to this report, the analysts had been modelling revenues of US$2.31b and earnings per share (EPS) of US$2.58 in 2024. So it looks like there's been a small decline in overall sentiment after the recent results - there's been no major change to revenue estimates, but the analysts did make a small dip in their earnings per share forecasts.

继上周的财报之后,Edgewell Personal Care的六位分析师预测2024年的收入为22.9亿美元,与过去12个月大致持平。法定每股收益预计为2.51美元,与过去12个月基本持平。在本报告发布之前,分析师一直在模拟2024年的收入为23.1亿美元,每股收益(EPS)为2.58美元。因此,在最近的业绩公布之后,整体情绪似乎略有下降——收入估计没有重大变化,但分析师的每股收益预测确实略有下降。

It might be a surprise to learn that the consensus price target was broadly unchanged at US$43.43, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Edgewell Personal Care at US$53.00 per share, while the most bearish prices it at US$35.00. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

得知共识目标股价基本维持在43.43美元,这可能会令人惊讶,分析师明确表示,预期的收益下降预计不会对估值产生太大影响。但是,还有另一种思考价格目标的方法,那就是研究分析师提出的价格目标范围,因为范围广泛的估计可能表明,对业务可能的结果有不同的看法。目前,最看涨的分析师对Edgewell个人护理的估值为每股53.00美元,而最看跌的分析师估值为35.00美元。这表明估值仍然存在一点差异,但分析师似乎对该股的看法并不完全分歧,好像这可能是成功或失败一样。

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The period to the end of 2024 brings more of the same, according to the analysts, with revenue forecast to display 1.8% growth on an annualised basis. That is in line with its 1.8% annual growth over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 6.9% per year. So although Edgewell Personal Care is expected to maintain its revenue growth rate, it's forecast to grow slower than the wider industry.

从现在的大局来看,我们可以理解这些预测的方法之一是看看它们如何与过去的业绩和行业增长预期相比较。分析师表示,截至2024年底将带来更多相同的情况,收入按年计算预计将增长1.8%。这与其在过去五年中1.8%的年增长率一致。相比之下,我们的数据表明,预计类似行业的其他公司(有分析师报道)的收入每年将增长6.9%。因此,尽管预计Edgewell个人护理将保持其收入增长率,但预计其增长速度将低于整个行业。

The Bottom Line

底线

The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Edgewell Personal Care. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. The consensus price target held steady at US$43.43, with the latest estimates not enough to have an impact on their price targets.

最大的担忧是,分析师下调了每股收益预期,这表明Edgewell Personal Care可能会面临业务不利因素。从好的方面来看,收入估计没有重大变化;尽管预测表明它们的表现将比整个行业差。共识目标股价稳定在43.43美元,最新估计不足以对其目标价格产生影响。

With that said, the long-term trajectory of the company's earnings is a lot more important than next year. We have forecasts for Edgewell Personal Care going out to 2026, and you can see them free on our platform here.

话虽如此,公司收益的长期轨迹比明年重要得多。我们对Edgewell个人护理的预测将持续到2026年,你可以在我们的平台上免费查看。

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Edgewell Personal Care that you should be aware of.

别忘了可能仍然存在风险。例如,我们已经确定了你应该注意的 Edgewell 个人护理的 1 个警告标志。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对这篇文章有反馈吗?对内容感到担忧?直接联系我们。 或者,给编辑团队 (at) simplywallst.com 发送电子邮件。
Simply Wall St的这篇文章本质上是笼统的。我们仅使用公正的方法根据历史数据和分析师的预测提供评论,我们的文章无意作为财务建议。它不构成买入或卖出任何股票的建议,也没有考虑到您的目标或财务状况。我们的目标是为您提供由基本数据驱动的长期重点分析。请注意,我们的分析可能不考虑最新的价格敏感型公司公告或定性材料。简而言之,华尔街没有持有任何上述股票的头寸。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的,不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发